CD19 and neoplasm: To determine the relative fraction of different lymphoid lineage cells in the blood and tumour tissue, we compared the proportion of CD3+ (T cells), CD19+ (B cells), CD56+ (NK cells) and CD3+CD56+ cells amongst the CD45+ fraction of cells from the blood and tumour (Fig 2A).